Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0220
0.00 (0.00%)
Feb 19, 2026, 4:15 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 77.97 million as of February 18, 2026. Its market cap has increased by 39.20% in one year.
Market Cap
77.97M
Enterprise Value
46.94M
Revenue
12.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 77.97M, a decrease of -23.05%. That is a compound annual growth rate of -6.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 77.97M | -12.00% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 104.85M |
| LTR Pharma | 89.98M |
| Cynata Therapeutics | 87.03M |
| Alterity Therapeutics | 87.00M |
| EZZ Life Science Holdings | 80.44M |
| Imugene | 80.38M |
| Neurizon Therapeutics | 67.49M |
| Prescient Therapeutics | 67.30M |